Restoring Balance, Transforming Neurology

We are harnessing the power of light to develop a precision neuromodulation platform using optogenetics to treat severe neurological disorders.

Our Mission

At Modulight Biotherapeutics we are pioneering a new era of medicine for people living with neurological disorders - one that is fast-acting, precise, and designed to provide real relief without side effects. Our mission is to help patients regain function and comfort in moments that matter most—whether it’s stopping a seizure, calming a tremor, or easing persistent pain.

Trigeminal neuropathic pain

Our first indication for clinical studies will be debilitating neuropathic pain. The location of the trigeminal nerve makes it an ideal candidate for light therapy.

Our Pipeline

News & Publications

View All

Modulight Biotherapeutics announces $12 million seed funding for novel optogenic therapy to treat neurological disorders

"Novel OptoGPCRs open new avenues in optogenetic modulation"

"Exploring GPCR-mediated optogenetic modulation of seizure networks in a pig model of Temporal Lobe Epilepsy"

"Efficient optogenetic silencing of neurotransmitter release with a mosquito rhodopsin"

Our Research Partners